Martin Hillsten

Hillsten, who was born in 1978, brings a wealth of experience to the role. He previously served as the CEO of Integration Diagnostics and has a long history in the sales and marketing of advanced medical devices in the US and globally. Hillsten holds a Bachelor of Business Administration from the University of Lincoln, UK, and has spent two decades in the life sciences industry, focusing on implant products and diagnostic imaging.

In his prior role at Integration Diagnostics, a firm that develops, manufactures, and markets products to assess the stability of an implant and its ability to integrate with bone tissue, Hillsten oversaw a business where 70% of revenues were derived from the US market. He has also held senior sales and marketing positions at Bracco Diagnostics and currently owns 42,000 shares in Integrum.